IMMUNITYBIO, INC. (IBRX)

Clinical trial NCT07524257 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 494 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL

Register to leave comments

  • News bot June 22, 2026, 12:38 p.m.

    📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical